.

Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Chubb
Johnson and Johnson
Queensland Health
Cerilliant
Fish and Richardson
Baxter
Federal Trade Commission
McKesson
Cantor Fitzgerald

Generated: December 15, 2017

DrugPatentWatch Database Preview

Hydrochlorothiazide; lisinopril - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for hydrochlorothiazide; lisinopril and what is the scope of hydrochlorothiazide; lisinopril freedom to operate?

Hydrochlorothiazide; lisinopril
is the generic ingredient in three branded drugs marketed by Apotex Inc, Aurobindo, Hikma Intl Pharms, Invagen Pharms, Ivax Sub Teva Pharms, Lupin, Mylan, Prinston Inc, Sandoz, Sun Pharm Inds Ltd, Teva, Watson Labs, Merck, and Alvogen Malta, and is included in fifteen NDAs. Additional information is available in the individual branded drug profile pages.

There are thirty-one drug master file entries for hydrochlorothiazide; lisinopril. Forty-four suppliers are listed for this compound.

Summary for hydrochlorothiazide; lisinopril

Pharmacology for hydrochlorothiazide; lisinopril

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Ivax Sub Teva PharmsLISINOPRIL AND HYDROCHLOROTHIAZIDEhydrochlorothiazide; lisinoprilTABLET;ORAL075776-001Jul 1, 2002ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Ivax Sub Teva PharmsLISINOPRIL AND HYDROCHLOROTHIAZIDEhydrochlorothiazide; lisinoprilTABLET;ORAL075776-003Jul 1, 2002ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Prinston IncLISINOPRIL AND HYDROCHLOROTHIAZIDEhydrochlorothiazide; lisinoprilTABLET;ORAL076230-003Jul 1, 2002ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Invagen PharmsLISINOPRIL AND HYDROCHLOROTHIAZIDEhydrochlorothiazide; lisinoprilTABLET;ORAL204058-002May 23, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
SandozLISINOPRIL AND HYDROCHLOROTHIAZIDEhydrochlorothiazide; lisinoprilTABLET;ORAL076262-001Jul 1, 2002ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Alvogen MaltaZESTORETIChydrochlorothiazide; lisinoprilTABLET;ORAL019888-003Nov 18, 1993ABRXYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Hikma Intl PharmsLISINOPRIL AND HYDROCHLOROTHIAZIDEhydrochlorothiazide; lisinoprilTABLET;ORAL076265-002Jul 8, 2002ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Apotex IncLISINOPRIL AND HYDROCHLOROTHIAZIDEhydrochlorothiazide; lisinoprilTABLET;ORAL076674-001Oct 5, 2004ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
SandozLISINOPRIL AND HYDROCHLOROTHIAZIDEhydrochlorothiazide; lisinoprilTABLET;ORAL075926-001Jul 1, 2002DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
MerckPRINZIDEhydrochlorothiazide; lisinoprilTABLET;ORAL019778-002Feb 16, 1989DISCNYesNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: hydrochlorothiazide; lisinopril

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Alvogen MaltaZESTORETIChydrochlorothiazide; lisinoprilTABLET;ORAL019888-003Nov 18, 1993► Subscribe► Subscribe
Alvogen MaltaZESTORETIChydrochlorothiazide; lisinoprilTABLET;ORAL019888-002Jul 20, 1989► Subscribe► Subscribe
MerckPRINZIDEhydrochlorothiazide; lisinoprilTABLET;ORAL019778-003Nov 18, 1993► Subscribe► Subscribe
Alvogen MaltaZESTORETIChydrochlorothiazide; lisinoprilTABLET;ORAL019888-003Nov 18, 1993► Subscribe► Subscribe
Alvogen MaltaZESTORETIChydrochlorothiazide; lisinoprilTABLET;ORAL019888-001Sep 20, 1990► Subscribe► Subscribe
MerckPRINZIDEhydrochlorothiazide; lisinoprilTABLET;ORAL019778-002Feb 16, 1989► Subscribe► Subscribe
MerckPRINZIDEhydrochlorothiazide; lisinoprilTABLET;ORAL019778-001Feb 16, 1989► Subscribe► Subscribe
Alvogen MaltaZESTORETIChydrochlorothiazide; lisinoprilTABLET;ORAL019888-001Sep 20, 1990► Subscribe► Subscribe
MerckPRINZIDEhydrochlorothiazide; lisinoprilTABLET;ORAL019778-002Feb 16, 1989► Subscribe► Subscribe
Alvogen MaltaZESTORETIChydrochlorothiazide; lisinoprilTABLET;ORAL019888-002Jul 20, 1989► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Citi
Argus Health
Chubb
Queensland Health
Daiichi Sankyo
Fuji
Cipla
Boehringer Ingelheim
Farmers Insurance
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot